drugset / Trial / NCT04300855
Clinical Trial of Green Tea Catechins in Men on Active Surveillance
Phase 2
Active not recruiting
115 enrolled
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI) · collab
RandomizedParallel-groupDouble-blindOther
Summary
This randomized double-blinded Phase II clinical trial will evaluate the bioavailability, safety, effectiveness and validate the mechanism by which a standardized formulation of whole Green Tea Catechin, (Sunphenon® 90D) containing 405 mgs vs. Placebo, administered for 24 months in a cohort of men with low to intermediate grade prostate managed on active surveillance
Timeline
- Start
- 2020-08-21
- Primary completion
- 2027-02-27
- Completion
- 2027-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | green tea extract | Unknown | 405 mg | — |